Latest blog articles
-
How do we guarantee access to COVID-19 vaccines and therapies, and secure health-related human rights for all? We’ve heard a string of promises in the race for new vaccines and therapies.
-
It’s been almost a month since the COVID-19 pandemic has drastically changed the way we live and work. Now that we are more used to, in a manner of speaking, the extraordinary measures to curtail the rampant spread of the virus, it’s time to seriously consider, and openly discuss, this crisis’...
-
This week I am having the pleasure of attending the 2019 BIO International Convention hosted in Philadelphia, Pennsylvania. The biggest global event of its kind, this international convention brings together stakeholders from across the biotechnologies. Whether it be from the health, agricultural or...
-
Globally the majority of health-related R&D is invested in medicines with substantial guaranteed returns, yet what is missing is extensive R&D targeted at diseases overwhelmingly prevalent in developing countries. This threatens long-term availability of medicines and treatment options for these...
-
From different angles it was called to finance public duties from the curator differently than from the estate, like to detect insolvencies fraud, for example from public resources. (Dutch only)
-
Abuse of partnership companies is a societal problem that has existed for decades... This blog is only available in Dutch.
-
Last Tuesday (27 October 2015) NLFI (the organisation responsible for managing state participation in the financial sector) and ABN AMRO group NV announced that they would be taking the next steps towards ... This article is only available in Dutch.